Physician profile
Christopher Khorsandi
NPI 1235376377
$41,798.96
in general payments reported to CMS, 2019-2025
13 companies · $85.70 in 2025
The $85.70 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $7,971 · 2021: $386 · 2022: $2,032 · 2023: $114 · 2024: $82.88 · 2025: $85.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $23,169.71 | 2019-2025 | |
| Allergan, INC. | $10,606.79 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $5,108.18 | 2019-2021 | |
| Surgical Innovation Associates, INC. | $1,916.12 | 2022 | |
| Galderma Laboratories, L.P. | $587.93 | 2019-2025 | Dysport |
| Mentor Worldwide LLC | $123.08 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Kci USA, INC. | $76.92 | 2021 | |
| Sientra, INC. | $71.95 | 2019 | |
| Tepha INC | $64.35 | 2019 | |
| Abbvie INC. | $41.89 | 2024 | |
| Sensus Healthcare, INC. | $14.61 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.44 | 2023 | Seglentis |
| Apyx Medical Corporation | $3.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Khorsandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.